As per MRFR analysis, the US Vascular Closure Devices Market Size was estimated at 338.1 (USD Million) in 2023. The US Vascular Closure Devices Market Industry is expected to grow from 367.5(USD Million) in 2024 to 847.64 (USD Million) by 2035. The US Vascular Closure Devices Market CAGR (growth rate) is expected to be around 7.894% during the forecast period (2025 - 2035).
The US Vascular Closure Devices Market is experiencing several significant trends driven by its healthcare landscape. One of the key market drivers is the rising prevalence of cardiovascular diseases within the country, prompting healthcare providers to seek innovative and effective solutions for vascular access. Additionally, the increasing number of diagnostic and therapeutic procedures, such as catheterizations, fuels the demand for vascular closure devices, as they play a crucial role in minimizing complications like bleeding and promoting faster recovery times for patients.
Opportunities in this market are vast, particularly with the ongoing advancements in technology.The development of minimally invasive procedures has created a favorable environment for deploying innovative vascular closure devices that are user-friendly and effective. The integration of smart technologies, such as devices that provide feedback to clinicians during procedures, is another avenue to explore, enhancing safety and efficiency. Recent trends indicate a growing shift towards device personalization and the customization of solutions to suit specific patient needs.
As healthcare systems focus on delivering high-quality patient care, manufacturers are increasingly emphasizing the development of products that cater to diverse anatomical variations and clinical scenarios.Furthermore, the ongoing focus on reducing hospital stay durations and recovery times is driving hospitals in the US to adopt these devices more extensively, aligning with broader healthcare objectives. Overall, the combination of technological advancements, rising procedural demands, and a patient-centered approach is shaping the evolution of the US Vascular Closure Devices Market significantly.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The US Vascular Closure Devices Market Industry is witnessing significant growth driven by the increasing prevalence of cardiovascular diseases (CVDs). According to the Centers for Disease Control and Prevention (CDC), CVDs affect nearly 697,000 people in the US annually, accounting for about 1 in every 5 deaths. This high incidence rate underscores the demand for surgical interventions and, consequently, the need for vascular closure devices that facilitate faster recovery times and minimize complications.
Organizations such as the American Heart Association (AHA) are actively promoting awareness and research, thereby influencing innovations and advancements in vascular closure devices. As the healthcare sector continues to prioritize heart health, the market's growth trajectory will likely remain strong in response to the rising CVD patient population, ensuring an ongoing need for effective vascular management solutions.
The advancement of technology in medical devices is acting as a significant catalyst for the US Vascular Closure Devices Market Industry. With innovations such as bioabsorbable materials and enhanced delivery systems, the efficacy of vascular closure devices has markedly improved. The Food and Drug Administration (FDA) has been proactive in approving various cutting-edge devices that reflect these advancements. For example, devices that utilize hemostatic mechanisms to optimize closure have gained traction in both clinical and outpatient settings.
As per the FDA, the rapid pace of innovation is expected to pave the way for new entrants and enhance current offerings, thus boosting the market's growth. The US's emphasis on Research and Development in healthcare technology plays a pivotal role in advancing patient outcomes and expanding the vascular closure market landscape.
The aging demographic in the US is poised to have a considerable impact on the US Vascular Closure Devices Market Industry. The U.S. Census Bureau projects that by 2030, approximately 20% of the US population will be aged 65 or older, representing over 73 million individuals. This demographic is particularly susceptible to conditions requiring surgical interventions, such as angioplasties and catheterizations. The National Institute on Aging reports that older adults often experience multiple comorbidities that necessitate vascular procedures.
As healthcare providers focus on catering to the specialized needs of the geriatric population, the demand for effective and efficient vascular closure devices is set to rise significantly. The active involvement of the AARP (formerly known as the American Association of Retired Persons) is also crucial in advocating for innovations and standards to improve care for this expanding group.
The US Vascular Closure Devices Market is a growing sector that plays a significant role in improving patient outcomes during and after vascular procedures. The Product Type segmentation of this market includes Passive Vascular Closure Devices, Active Vascular Closure Devices, and External Hemostatic Devices, each serving distinct yet vital functions in clinical settings. Passive Vascular Closure Devices are particularly notable for their simplicity and effectiveness, as they rely on natural physiological mechanisms to achieve hemostasis, thereby reducing procedural time and minimizing complications.
In contrast, Active Vascular Closure Devices utilize mechanical or other active means to enhance hemostatic effectiveness, offering advantages in specific procedural scenarios where immediate closure is paramount. This active component is essential in complex procedures, indicating their importance in emergency and high-risk situations. External Hemostatic Devices, on the other hand, offer an adjunctive approach for controlling bleeding, often used in combination with other closure strategies; their significance lies in their versatility and the ability to be applied non-invasively.
The increasing prevalence of cardiovascular diseases and the growing number of interventional procedures are driving the market growth, as healthcare providers continuously seek to enhance procedural efficacy and patient safety. Innovations in technology and materials are evolving the design and functionality of these products, leading to improved performance and outcomes. Furthermore, with the rise of outpatient procedures, the demand for efficient and effective vascular closure solutions has surged, establishing a solid trajectory for future growth within the Product Type segment of the US Vascular Closure Devices Market.
This interest in various closure methods stems from a mix of factors, including patient preferences for less invasive solutions and the emphasis on cost-effective clinical practices in the US healthcare landscape. The interplay among these sub-segments highlights a robust and competitive market environment, ensuring that advancements in Vascular Closure Devices continue to align with the demands of modern medicine.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The Access segment of the US Vascular Closure Devices Market represents a critical area as it facilitates safe and efficient access during catheterization procedures. Dominant access approaches, especially the Femoral and Radial methods, play significant roles in enhancing procedural outcomes. The Femoral access route has historically been preferred due to its reliability in achieving vascular access for diagnostics and interventions; however, the Radial approach has gained traction due to its association with reduced complications and shorter recovery times.
Factors driving growth within this segment include an increasing prevalence of cardiovascular diseases, the aging US population, and advancements in technology that improve device efficiency and safety. Additionally, healthcare professionals are increasingly prioritizing patient comfort and recovery, contributing to the growing preference for radial access. The market dynamics are also influenced by ongoing Research and Development initiatives aimed at innovating vascular closure solutions and improving procedural techniques, ensuring that the Access segment remains pivotal in the US Vascular Closure Devices Market.
As procedural volumes rise, the importance of effective vascular access strategies will continue to shape the landscape in this segment.
The US Vascular Closure Devices Market Procedures segment has been experiencing significant growth, driven by increasing prevalence of cardiovascular diseases and advancements in minimally invasive procedures. Within this segment, Interventional Cardiology plays a crucial role as it addresses coronary artery disease and related conditions, allowing for faster recovery times and reduced hospital stays. The growing geriatric population and rising adoption of cardiac surgeries significantly contribute to this part of the market.
Similarly, Interventional Radiology holds a prominent position in the Procedures segment, offering effective treatment options for a variety of conditions through image-guided techniques which enhance accuracy and minimize risks.These trends highlight the increasing reliance on vascular closure devices in both specialties, with crucial implications for improving patient outcomes and healthcare efficiency. The ongoing innovation in device technology and methodologies promises to solidify the significance of these procedures within the US Vascular Closure Devices Market, catering to the evolving needs of healthcare professionals and patients alike.
As a result, the Procedures segment is poised for substantial expansion, reflecting the broader dynamics of the market driven by clinical advancements and rising demand for effective vascular interventions.
The US Vascular Closure Devices Market, particularly in the Application segment, encompasses both Diagnostic and Therapeutic uses, reflecting the market's diverse functionalities and increasing demand. In the Diagnostic area, vascular closure devices are crucial for post-procedural closure, ensuring minimal complications and enhancing patient recovery. This segment is expected to leverage technological advancements in design and materials, which play a vital role in improving procedural outcomes.
On the other hand, the Therapeutic Application segment addresses the critical need for effective intervention in various cardiovascular conditions, significantly influencing treatment protocols.The growth within this segment is driven by the rising prevalence of vascular diseases in the United States, further supported by an increasing focus on minimally invasive procedures. The overall trend indicates a robust integration of innovative solutions that cater to both diagnostic evaluations and therapeutic requirements, promising efficient patient management.
As the healthcare industry in the US continues to evolve, these applications stand as pivotal components of the Vascular Closure Devices Market, making significant contributions to healthcare outcomes and operational efficiency.
The competitive insights of the US Vascular Closure Devices Market reveal a dynamic landscape characterized by rapid technological advancements and an increasing focus on patient outcomes. This market is defined by a variety of players ranging from established corporations to emerging startups, each vying for market share through innovations in product design, efficacy, and safety. Vascular closure devices are critical tools used to minimize complications and accelerate recovery post-intervention for various vascular procedures, making their competitiveness crucial in hospital settings and for outpatient procedures.
The competitive environment is also shaped by evolving regulatory standards, advancements in minimally invasive techniques, and an increasing aging population that necessitates improved vascular care. Companies are continuously investing in research and development to enhance their offerings while monitoring market trends to address the changing healthcare demands.
Teleflex has established a significant presence in the US Vascular Closure Devices Market through its commitment to innovation and quality. The company's strength lies in its diverse portfolio of vascular closure products, which are designed to improve safety and efficiency in hemostasis after catheterization procedures. Teleflex's products are known for their reliability, ease of use, and minimal complication rates, which have garnered trust among clinicians and healthcare professionals.
Furthermore, Teleflex has built strong relationships with various healthcare institutions, allowing for widespread adoption of its devices across the United States. The company leverages its extensive experience and robust manufacturing capabilities to remain competitive in this evolving market, continuously pushing for enhancements in their product offerings and expanding its presence through strategic marketing and educational initiatives targeted at healthcare providers.
Imperial Medical is also a notable player in the US Vascular Closure Devices Market, focusing on delivering innovative solutions designed for improved patient outcomes. The company specializes in several key products that aim to simplify the vascular closure process while ensuring robust performance and decreased risk of complications. With a strategic presence in the market, Imperial Medical emphasizes customer engagement and feedback, utilizing these insights to refine its product development continually.
The company is also known for its collaborative approach, which includes partnerships, mergers, and acquisitions aimed at enhancing its technological capabilities and expanding its product portfolio. This positioning allows Imperial Medical to respond swiftly to market needs while maintaining a competitive edge through improved offerings and services tailored specifically for the US healthcare sector.
In recent months, the US Vascular Closure Devices Market has experienced notable developments, particularly with companies such as Teleflex, Terumo Corporation, and Abbott Laboratories driving innovation within the sector. In September 2023, Medtronic launched a next-generation vascular closure device aimed at improving patient outcomes and decreasing complication rates. This launch underscores the ongoing technological advancements in the market.
Furthermore, reports indicate Boston Scientific is actively exploring strategic partnerships to enhance its product offerings, while Merit Medical Systems announced plans to expand its manufacturing capabilities in the US to meet increasing demand. In terms of mergers and acquisitions, Teleflex completed its acquisition of a vascular access company in August 2023, enhancing its portfolio in the closure device segment. Similarly, Cardinal Health announced in July 2023 a merger with a healthcare technology firm to integrate advanced solutions for vascular procedures.
The market's valuation has continued to rise, reflecting an increasing prevalence of cardiovascular diseases in the US and a growing patient population undergoing interventional procedures. This factors into the ongoing demand for advanced vascular closure solutions to enhance surgical efficiency and improve patient safety.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 338.1(USD Million) |
| MARKET SIZE 2024 | 367.5(USD Million) |
| MARKET SIZE 2035 | 847.64(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.894% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Teleflex, Imperial Medical, Terumo Corporation, Medtronic, Abbott Laboratories, Boston Scientific, Merit Medical Systems, Civco Medical Solutions, Spiggle and Theis, Cardinal Health, Siemens Healthineers, Vascular Solutions, AngioDynamics, Johnson and Johnson, Becton Dickinson |
| SEGMENTS COVERED | Product Type, Access, Procedures, Application |
| KEY MARKET OPPORTUNITIES | Government initiatives for minimally invasive procedures, Increasing demand for outpatient surgeries, Advancements in device technology, Growing geriatric population requiring vascular interventions, Rising prevalence of cardiovascular diseases. |
| KEY MARKET DYNAMICS | Growing prevalence of cardiovascular diseases, Advancements in minimally invasive procedures, Increasing awareness of vascular health, Rising demand for outpatient surgeries, Technological innovations in device design |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
By 2035, the US Vascular Closure Devices Market is expected to reach a valuation of approximately 847.64 million USD.
In 2024, the market value of the US Vascular Closure Devices Market was estimated to be 367.5 million USD.
The expected CAGR for the US Vascular Closure Devices Market from 2025 to 2035 is 7.894 percent.
The key product types in the market include Passive Vascular Closure Devices, Active Vascular Closure Devices, and External Hemostatic Devices.
By 2035, Active Vascular Closure Devices are anticipated to hold the largest market size, valued at approximately 350.67 million USD.
Major players in the market include Teleflex, Medtronic, Abbott Laboratories, Boston Scientific, and Johnson & Johnson, among others.
The market value for Passive Vascular Closure Devices is projected to be about 290.54 million USD by 2035.
Emerging trends include advancements in device technology, increasing procedural volumes, and growing demand for minimally invasive surgeries.
In 2035, External Hemostatic Devices are expected to reach a market value of approximately 206.43 million USD.
Challenges include stringent regulatory requirements, product recalls, and competition from alternative closure methods.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
